Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well docosahexaenoic acid works in preventing
recurrence in breast cancer survivors. Docosahexaenoic acid supplement may prevent recurrence
in breast cancer survivors.